Jobs / United States / Gilead Sciences INC
Director, Strategic Evidence and Collaborations, US Medical Affairs
Gilead Sciences INC · 🇺🇸 United States - California - Bay Area Remote · Remote
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Gilead Sciences INC paid sponsored hires in similar roles2 certified filings for “Associate Director, Patient Safety” (Medical and Health Services Managers) in CA: $209k–$226k, median $217k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Gilead Sciences INC
The US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Gilead Sciences INC →
About the role
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together. Job Description We have an exciting opportunity within US Medical Affairs for a Director, Medical Affairs Oncology, Strategic Evidence & Collaborations (SEC) . This role will be remote but will require headquarters travel for specific meetings quarterly. Reporting to the Senior Director and Head of Strategic Evidence & Collaborations, US Medical Affairs (USMA), the core efforts of this role is to be responsible for co-developing the US Medical Affairs strategy for US Medical Affairs congress plans in collaboration with the COE (Congress Center of Excellence) and the USMA Strategy and Field Based Medical Teams. The key functions of this role will be to represent and consider the healthcare environment of the US with internal and external stakeholders involved in cancer therapies across approved and pipeline molecules and indications, including the Global Medical Affairs team, US Medical Access and Quality team, Scientific Communications/Publications, Medical Affairs Outcomes Research, Commercial Strategy, Marketing, Value and Market Access, Clinical Research/Development, US Public Affairs, US Government Affairs ,Patient Engagement, Business Conduct (Legal), and the field-based US Medical Science Liaisons. Travel Requirement: Must be able to travel more than 50% of the time, including a mix of domestic and international travel. Job Responsibilities As an integral part of the USMA Oncology team, and in close collaboration with Oncology medical directors, Field Medical., Global Medical Affairs, Medical Affairs Research, Medical Patient Access and Quality, and cross-functional partners, this role will establish and execute an overarching strategy for evidence generation across various tumor types in the US, including collaboration with cooperative groups, NCI/CTEP, and other key organizations. This role will also provide frequent internal and external input into the development of both the US and Global Medical Affairs Strategic Plans for our ADC portfolio, particularly the Integrated Strategic Plan (ISP). Additionally, the role will be a key contributor to the US and Global medical Plan of Action (POA) Specific responsibilities for this role will include, but are not limited to: • Demonstrate deep subject matter expertise in our full ADC portfolio, the Gilead clinical trials and their clinical use, as well as competitive products • Collaborate as a thought partner and significant contributor to the successful work lead by the Community Cancer Collective Team (CCC) • Contribute to the development of the Global Integrated Strategic Plan (ISP) and Local Plan of Action (POAs) by pr